Guideline Group Composition and Group Processes

Kunz, Regina; Fretheim, Atle; Cluzeau, Françoise; Wilt, Timothy J; Qaseem, Amir; Lelgemann, Monika; Kelson, Marcia; Guyatt, Gordon

doi:10.1513/pats.201208-056st

Cited by 25 publications

(11 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This should improve “applicability” scores. Additionally, actions toward intensifying healthcare professionals’ participation in CPG development may also improve recommendation adherence [80,81], along with important domain scores. In Brazil, most CPG developers did not create multidisciplinary teams.…”

Section: Discussionmentioning

confidence: 99%

Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency

et al. 2016

View full text Add to dashboard Cite

BackgroundAnnually, non-communicable diseases (NCDs) kill 38 million people worldwide, with low and middle-income countries accounting for three-quarters of these deaths. High-quality clinical practice guidelines (CPGs) are fundamental to improving NCD management. The present study evaluated the methodological rigor and transparency of Brazilian CPGs that recommend pharmacological treatment for the most prevalent NCDs.MethodsWe conducted a systematic search for CPGs of the following NCDs: asthma, atrial fibrillation, benign prostatic hyperplasia, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease and/or stable angina, dementia, depression, diabetes, gastroesophageal reflux disease, hypercholesterolemia, hypertension, osteoarthritis, and osteoporosis. CPGs comprising pharmacological treatment recommendations were included. No language or year restrictions were applied. CPGs were excluded if they were merely for local use and referred to NCDs not listed above. CPG quality was independently assessed by two reviewers using the Appraisal of Guidelines Research and Evaluation instrument, version II (AGREE II).Main Findings“Scope and purpose” and “clarity and presentation” domains received the highest scores. Sixteen of 26 CPGs were classified as low quality, and none were classified as high overall quality. No CPG was recommended without modification (77% were not recommended at all). After 2009, 2 domain scores (“rigor of development” and “clarity and presentation”) increased (61% and 73%, respectively). However, “rigor of development” was still rated < 30%.ConclusionBrazilian healthcare professionals should be concerned with CPG quality for the treatment of selected NCDs. Features that undermined AGREE II scores included the lack of a multidisciplinary team for the development group, no consideration of patients’ preferences, insufficient information regarding literature searches, lack of selection criteria, formulating recommendations, authors’ conflict of interest disclosures, and funding body influence.

show abstract

Section: Discussionmentioning

confidence: 99%

Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency

et al. 2016

View full text Add to dashboard Cite

show abstract

“…A GDG necessitates the expertise of healthcare professionals, patient input on their needs and preferences and methodologists and librarians skilled in gathering, summarising and interpreting evidence 34. Structured education in this methodological area will be required, given the increasing demands and expertise required to manage complex guideline development projects 35. The focus of the guidelines should influence the number of group members and the balance of disciplines.…”

Section: Discussionmentioning

confidence: 99%

“…The focus of the guidelines should influence the number of group members and the balance of disciplines. When deciding on the group’s composition, all potential stakeholders should be identified, including healthcare professionals who are directly involved in the clinical management of patients in various healthcare settings (eg, primary and secondary care), policymakers who may need to make resource usage decisions and patients 35. The decision must then be made about which categories of participants to include in the guideline group.…”

Section: Discussionmentioning

confidence: 99%

Quality assessment of clinical practice guidelines in Kenya using the AGREE II tool: a methodological review

et al. 2023

View full text Add to dashboard Cite

ObjectiveTo assess the quality of available and accessible national Clinical Practice Guidelines (CPGs) in Kenya using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool.MethodsWe searched the websites of the Kenyan Ministry of Health, professional associations and contacted experts in relevant organisations. Our scope was guidelines on maternal, neonatal, nutritional disorders, injuries, communicable and non-communicable diseases in Kenya published in the last 5 years until 30 June 2022. Study selection and data extraction were done by three independent reviewers with disagreements resolved via discussion or with a senior reviewer. We conducted a quality assessment using the online English version of AGREE II tool across six domains. Descriptive statistics were analysed using Stata software V.17. The primary outcome was the methodological quality of the included CPGs assessed by the AGREE II tool score.ResultsWe retrieved 95 CPGs and included 24 in the analysis after screening for eligibility. The CPGs scored best in clarity of presentation and least in the rigour of development. In descending order, the appraisal scores (mean and CI) per domain were as follows: Clarity of presentation 82.96% (95% CI 78.35% to 87.57%) with all guidelines scoring above 50%. Scope and purpose 61.75% (95% CI 54.19% to 69.31%) with seven guidelines scoring less than 50%. Stakeholder involvement 45.25% (95% CI 40.01% to 50.49%) with 16 CPGs scoring less than 50%. Applicability domain 19.88% (95% CI 13.32% to 26.43%) with only one CPG scoring above 50%. Editorial independence 6.92% (95% CI 3.47% to 10.37%) with no CPG scoring above 50% and rigour of development 3% (95% CI 0.61% to 5.39%) with no CPG scoring at least 50%.ConclusionOur findings suggest that the quality of CPGs in Kenya is limited mainly by the rigour of development, editorial independence, applicability and stakeholder involvement. Training initiatives on evidence-based methodology among guideline developers are needed to improve the overall quality of CPGs for better patient care.

show abstract

“…É particularmente preocupante que os domínios "envolvimento das partes interessadas" e "aplicabilidade" tenham recebido notas tão baixas na avaliação. É importante que ao elaborar GPC incluam equipe multiprofissional, assim como representantes de pacientes, pois estudos sugerem que a inclusão de outros profissionais da saúde assim como a inclusão de representantes de pacientes na elaboração dos GPC melhoram a adesão a esses documentos (152)(153)(154). No caso do domínio "envolvimento das partes interessadas", a pontuação média geral foi mais baixa do que a reportada em outros estudos (15,49,150).…”

Section: Grade Adaptadounclassified

“…Também em 2018, foi publicado um estudo que visava avaliar a associação entre as taxas de mortalidade, doença cardiovascular, e eventos adversos relacionados ao tratamento farmacológico de pacientes com HAS leve (140)(141)(142)(143)(144)(145)(146)(147)(148)(149)(150)(151)(152)(153)(154)(155)(156)(157)(158)(159). Nesse estudo foram analisados dados de 38.286 pacientes, com idade entre 18 e 74 anos, acompanhados por um período médio de 5,8 anos, com HAS leve e sem fator de risco aumentado para eventos cardiovasculares no período de 1995 a 2015.…”

Section: Grade Adaptadounclassified

Matriz de recomendações para farmacoterapia da Hipertensão Arterial Sistêmica: recurso para subsidiar a adaptação de guias de prática clínica

Santos¹

View full text Add to dashboard Cite

show abstract

Guideline Group Composition and Group Processes

Cited by 25 publications

References 14 publications

Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency

Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency

Quality assessment of clinical practice guidelines in Kenya using the AGREE II tool: a methodological review

Matriz de recomendações para farmacoterapia da Hipertensão Arterial Sistêmica: recurso para subsidiar a adaptação de guias de prática clínica

Contact Info

Product

Resources

About